AIM IMMUNOTECH INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
AIM IMMUNOTECH INC. (AIM) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of -$826.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2018-11-14
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2018-09-30 was -$695.00K.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2018-06-30 was -$362.00K, a 127.51% decline year-over-year.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2018-03-31 was $231.00K.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-12-31 was -$32.00K.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2017 was -$2.42M.
- AIM IMMUNOTECH INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2016 was -$1.68M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$695.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.06M derived: sum of 2 quarters · filed 2018-11-14 | -$826.00K 10-Q · filed 2018-11-14 | -$858.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | -$362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$131.00K 10-Q · filed 2018-08-14 | -$163.00K derived: sum of 3 quarters · filed 2018-08-14 | -$3.47M derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | $231.00K 10-Q · filed 2018-05-15 | $199.00K derived: sum of 2 quarters · filed 2018-05-15 | -$3.11M derived: sum of 3 quarters · filed 2018-05-15 | -$1.79M derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$3.34M derived: sum of 2 quarters · filed 2018-03-30 | -$2.02M derived: sum of 3 quarters · filed 2018-03-30 | -$2.42M 10-K · filed 2018-03-30 |
| 2017-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$1.99M derived: sum of 2 quarters · filed 2017-11-14 | -$2.38M 10-Q · filed 2017-11-14 | -$3.96M derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $923.00K 10-Q · filed 2017-08-14 | -$651.00K derived: sum of 3 quarters · filed 2017-08-14 | |
| 2017-03-31 | -$393.00K 10-Q · filed 2017-05-15 | -$1.97M derived: sum of 2 quarters · filed 2017-05-15 | ||
| 2016-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$1.68M 10-K · filed 2017-03-31 | ||
| 2016-09-30 | -$103.00K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |